Education
About Us
Working with TipRanks
Follow Us
Bassam Kanaan Insider Profile
4 Followers
Bassam Kanaan, Chief Strategy Officer at Hikma Pharmaceuticals, holds 493.50K shares in Hikma Pharmaceuticals (Ticker: GB:HIK). Most recently, Bassam Kanaan Sold 40,000p shares of Hikma Pharmaceuticals on Jun 09, 2025 for an estimated value of 842.00K.
Bassam Kanaan Hikma Pharmaceuticals (HIK)Chief Strategy Officer
Hikma Pharmaceuticals (HIK)
Chief Strategy Officer
Ranked #21,432 out of 102,830 Corporate Insiders
Profitable Transactions
7 out of 11 Profitable Transactions
Average Return
+6.30%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chief Strategy Officer
Roles that Bassam Kanaan holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Mar 23, 2017 - Mar 23, 2018
Return:+43.70%
The most profitable trade made by Bassam Kanaan
Bassam Kanaan's Trading History
List of latest transactions for each holding click on a transaction to see Bassam Kanaan's performance on stock
You May Also Like
Bassam Kanaan insider profile FAQ
What is the percentage of profitable transactions made by Bassam Kanaan?
The percentage of profitable transactions made by Bassam Kanaan is 64%.
What is the average return per transaction made by Bassam Kanaan?
The average return per transaction made by Bassam Kanaan is 6.30%.
What stocks does Bassam Kanaan hold?
Bassam Kanaan holds: GB:HIK stocks.
What was Bassam Kanaan’s latest transaction?
Bassam Kanaan latest transaction was an Informative Sell of 842.00K.
What was Bassam Kanaan's most profitable transaction?
Bassam Kanaan’s most profitable transaction was an Informative Sell of GB:HIK stock on March 23, 2017. The return on the trade was 43.70%.
What is Bassam Kanaan's role in Hikma Pharmaceuticals?
Bassam Kanaan's role in Hikma Pharmaceuticals is Chief Strategy Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.